Cala Health

Cala Health is a bioelectronics company developing transformative therapies for neurological disorders. The company combines cutting-edge science with emerging technologies to adapt the language of the nervous system and empower people to get back to doing the things they love.


Omada Health is a digital behavioral medicine company that inspires people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings world-class behavioral medicine to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle.

Science 37

Science 37 is a technology-enabled clinical research company. They created a new clinical trial operating model – the metasite™ – that unlocks access so researchers can find the right patients, and patients can find the right trials. Their Network Oriented Research Assistant, NORA™, is the cloud-based patient-centric mobile research platform that connects everyone – safely and securely. Science 37 offers end-to-end clinical trial services without geographic limitations, making clinical research faster to accelerate biomedical discovery. Ultimately, Science 37 enables better, faster people-powered science and brings clinical trials to scale.

© 2016 dRx Capital, a joint investment company of Novartis & Qualcomm Incorporated. Novartis is a registered trademark of Novartis AG. Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries. All Rights Reserved.